Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,469,414 | 2,316,400 | 2,357,588 | 2,135,270 | 1,897,300 |
| Receivables | 717,417 | 624,697 | 676,347 | 646,386 | 673,307 |
| Inventories | 170,325 | 164,496 | 169,559 | 190,258 | 203,680 |
| TOTAL | $3,921,964 | $3,602,847 | $3,652,843 | $3,412,009 | $3,203,094 |
| Non-Current Assets | |||||
| PPE Net | 362,326 | 355,872 | 340,509 | 317,692 | 302,260 |
| Intangibles | 3,497,103 | 3,586,701 | 3,675,315 | 3,768,232 | 3,861,181 |
| Other Non-Current Assets | 1,517,348 | 1,448,030 | 1,445,949 | 1,529,929 | 1,486,938 |
| TOTAL | $5,376,777 | $5,390,603 | $5,461,773 | $5,615,853 | $5,650,379 |
| Total Assets | $9,298,741 | $8,993,450 | $9,114,616 | $9,027,862 | $8,853,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Accounts payable and accrued liabilities | 85,543 | 76,619 | 155,800 | 32,113 | 18,538 |
| Accrued Expenses | 496,669 | 482,334 | 457,557 | 457,288 | 419,036 |
| TOTAL | $917,681 | $884,888 | $949,137 | $860,614 | $791,061 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,541,458 | 2,544,230 | 2,546,837 | 2,549,140 | 2,550,989 |
| Other Non-Current Liabilities | 263,828 | 197,222 | 204,451 | 199,300 | 199,645 |
| TOTAL | $3,070,101 | $3,013,002 | $3,093,305 | $3,133,561 | $3,116,881 |
| Total Liabilities | $3,987,782 | $3,897,890 | $4,042,442 | $3,994,175 | $3,907,942 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 228,995 | 228,622 | 228,448 | 226,622 | 230,384 |
| Common Shares | 23 | 23 | 23 | 23 | 23 |
| Retained earnings | 771,764 | 644,693 | 590,009 | 606,280 | 583,840 |
| Other shareholders' equity | 22,027 | 7,100 | 12,943 | 7,875 | -14,676 |
| TOTAL | $5,310,959 | $5,095,560 | $5,072,174 | $5,033,687 | $4,945,531 |
| Total Liabilities And Equity | $9,298,741 | $8,993,450 | $9,114,616 | $9,027,862 | $8,853,473 |